13F-HR filed by Foresite Capital Management IV, LLC
Foresite Capital Management IV, LLC filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-13, with 21 holding rows worth $305,020,000.
- Accession
- 0001144204-18-059272
- Filer
- CIK 1704132
- Filed
- 2018-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 21 entries on the cover page, a total value of $305,020,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $305,020,000 with VALUE read as thousands by filing date, 13F file number 028-18415. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,800,587 | $36,408,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 511,244 | $33,333,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 851,200 | $31,963,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,231,543 | $25,653,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 2,676,825 | $25,296,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,023,369 | $22,419,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 696,903 | $20,329,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,229,656 | $19,797,000 | thousands by filing date | |
| OPTINOSE INC | 68404V100 | COM | 1,458,545 | $18,130,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 245,424 | $17,391,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 1,000,919 | $16,665,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 356,000 | $8,690,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 529,551 | $7,689,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 525,000 | $5,240,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 385,714 | $5,091,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 295,000 | $4,112,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 175,000 | $2,492,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 94,477 | $2,409,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 49,600 | $1,421,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 10,650 | $388,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 8,302 | $104,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-18-059272 | this filing | 2018-11-13 | acceptance time not in the bulk data set |